Capricor Therapeutics's total assets for Q1 2025 were $153.77M, a decrease of -9.80% from the previous quarter. CAPR total liabilities were $26.12M for the fiscal quarter, a 4.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.